Search

Your search keyword '"Kokosi, M"' showing total 124 results

Search Constraints

Start Over You searched for: Author "Kokosi, M" Remove constraint Author: "Kokosi, M"
124 results on '"Kokosi, M"'

Search Results

1. A comparison of long-term outcomes in patients managed with venovenous extracorporeal membrane oxygenation in the first and second waves of the COVID-19 pandemic in the United Kingdom

3. COVID-19 in patients with Pulmonary Alveolar Proteinosis A European multicenter study

4. Extensive autoantibody panel in Systemic sclerosis associated Interstitial Lung Disease

5. Responder status and long term outcomes of critically ill patients with ARDS receiving high dose steroids as rescue therapy in a specialist acute respiratory failure centre

6. P249 Predictors of adverse outcome in sarcoidosis complicated by chronic pulmonary aspergillosis

10. Predictors of uptake of ambulatory oxygen on completion of the ambox trial, a study to assess effects of ambulatory oxygen on quality of life in patients with fibrotic interstitial lung disease: S57

11. Rituximab versus Cyclophosphamide for the Treatment of Connective Tissue Disease Associated Interstitial Lung Disease (RECITAL): A Multi-Centre Randomised Controlled Trial

12. P145 Marginal short term lung function changes predict mortality in patients with fibrotic hypersensitivity pneumonitis

14. P4 Lung cancer screening provides a unique opportunity for early diagnosis and management of interstitial lung diseases

15. Outcome of hospitalisation for COVID-19 in patients with interstitial lung disease: an international multicentre study

16. Diagnostic accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis: an international case-cohort study

19. Identifying causation in hypersensitivity pneumonitis: a British perspective

20. Right ventricle to left ventricle ratio at CTPA predicts mortality in interstitial lung disease

22. Predicting outcomes in idiopathic pulmonary fibrosis using automated CT analysis

23. P60 Temporally close presentation of primary lung cancer and idiopathic pulmonary fibrosis (IPF): an analysis of incident IPF cases from 2007 – 2018

24. S69 Verification of genetic associations with scleroderma associated interstitial lung disease

27. S86 Serum biomarkers in SSc-ILD: association with presence, severity and prognosis

28. In Treated Patients with Idiopathic Pulmonary Fibrosis Hiatus Hernia but Not Acid Reflux Predicts Disease Progression and Survival

30. Functional associations of pleuroparenchymal fibroelastosis and emphysema with hypersensitivity pneumonitis

31. Pulmonary hypertension in interstitial lung disease: Limitations of echocardiography compared to cardiac catheterization

32. Likelihood of pulmonary hypertension in patients with idiopathic pulmonary fibrosis and emphysema

34. S76 Pleuro-parenchymal fibroelastosis: traction bronchiectasis and extent of platythorax on computed tomography are determinants of disease progression and mortality

36. S143 Serum CYFRA 21–1 as a prognostic marker in scleroderma-associated interstitial lung disease

38. P84 Advanced stage and aggressive cancers form a considerable proportion of lung malignancies in idiopathic pulmonary fibrosis and scleroderma-associated ILD

40. Functional associations of pleuroparenchymal fibroelastosis and emphysema with hypersensitivity pneumonitis

42. P158 Pulmonary vascular disease markers predict death in interstitial lung disease patients proven not to have pulmonary hypertension at right heart catheter

43. S55 Derivation and validation of a simple longitudinal score which strongly predicts mortality in interstitial lung disease (ild) associated pulmonary hypertension (ild-ph)

44. S56 The impact of azithromycin in idiopathic pulmonary fibrosis

45. S57 Predictors of uptake of ambulatory oxygen on completion of the ambox trial, a study to assess effects of ambulatory oxygen on quality of life in patients with fibrotic interstitial lung disease

49. Reconciling Healthcare Professional and Patient Perspectives in the Development of Disease Activity and Response Criteria in Connective Tissue Disease Related Interstitial Lung Diseases

50. Connective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: Provisional core sets of domains and instruments for use in clinical trials

Catalog

Books, media, physical & digital resources